DK199588D0 - Vaccine - Google Patents

Vaccine

Info

Publication number
DK199588D0
DK199588D0 DK199588A DK199588A DK199588D0 DK 199588 D0 DK199588 D0 DK 199588D0 DK 199588 A DK199588 A DK 199588A DK 199588 A DK199588 A DK 199588A DK 199588 D0 DK199588 D0 DK 199588D0
Authority
DK
Denmark
Prior art keywords
toxin
analog
detoxified
pasteurella multocida
vaccine
Prior art date
Application number
DK199588A
Other languages
English (en)
Inventor
Niels Taekker Foged
Svend Petersen
Original Assignee
Nordisk Droge & Kemikalie
Statens Veterinaere Serumlabor
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nordisk Droge & Kemikalie, Statens Veterinaere Serumlabor filed Critical Nordisk Droge & Kemikalie
Priority to DK199588A priority Critical patent/DK199588D0/da
Publication of DK199588D0 publication Critical patent/DK199588D0/da
Priority to AT89905073T priority patent/ATE107516T1/de
Priority to IE115189A priority patent/IE64033B1/en
Priority to DE68916424T priority patent/DE68916424T2/de
Priority to DE1989905073 priority patent/DE409895T1/de
Priority to US07/582,945 priority patent/US5369019A/en
Priority to EP89905073A priority patent/EP0409895B1/en
Priority to PCT/DK1989/000084 priority patent/WO1989009617A1/en
Priority to AU35320/89A priority patent/AU3532089A/en
Priority to DK230890A priority patent/DK169749B1/da
Priority to US08/293,314 priority patent/US6110470A/en
Priority to US08/453,141 priority patent/US5885589A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1242—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/832—Drug, bio-affecting and body treating compositions involving bacterial toxin that has modified amino acid sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Urology & Nephrology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Pulmonology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DK199588A 1988-04-12 1988-04-12 Vaccine DK199588D0 (da)

Priority Applications (12)

Application Number Priority Date Filing Date Title
DK199588A DK199588D0 (da) 1988-04-12 1988-04-12 Vaccine
AU35320/89A AU3532089A (en) 1988-04-12 1989-04-11 A pasteurella vaccine
DE1989905073 DE409895T1 (de) 1988-04-12 1989-04-11 Pasteurella-impfstoff.
IE115189A IE64033B1 (en) 1988-04-12 1989-04-11 A pasteurella vaccine
DE68916424T DE68916424T2 (de) 1988-04-12 1989-04-11 Pasteurella-impfstoff.
AT89905073T ATE107516T1 (de) 1988-04-12 1989-04-11 Pasteurella-impfstoff.
US07/582,945 US5369019A (en) 1988-04-12 1989-04-11 Pasteurella vaccine
EP89905073A EP0409895B1 (en) 1988-04-12 1989-04-11 A pasteurella vaccine
PCT/DK1989/000084 WO1989009617A1 (en) 1988-04-12 1989-04-11 A pasteurella vaccine
DK230890A DK169749B1 (da) 1988-04-12 1990-09-24 DNA-fragment, der koder for et Pasteurella multocida-toxin eller for en immunogen subsekvens eller analog deraf, ekspressionsvektor, der omfatter DNA-fragmentet, fremgangsmåde til fremstilling af et Pasteurella multocida-toxin og anvendelse af Pasteurella multocida-toxinsekvens eller -analog til fremstilling af en vaccine
US08/293,314 US6110470A (en) 1988-04-12 1994-08-22 Pasteurella multocida toxin derivatives
US08/453,141 US5885589A (en) 1988-04-12 1995-05-30 Pasteurella vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK199588A DK199588D0 (da) 1988-04-12 1988-04-12 Vaccine

Publications (1)

Publication Number Publication Date
DK199588D0 true DK199588D0 (da) 1988-04-12

Family

ID=8109323

Family Applications (1)

Application Number Title Priority Date Filing Date
DK199588A DK199588D0 (da) 1988-04-12 1988-04-12 Vaccine

Country Status (8)

Country Link
US (2) US5369019A (da)
EP (1) EP0409895B1 (da)
AT (1) ATE107516T1 (da)
AU (1) AU3532089A (da)
DE (1) DE68916424T2 (da)
DK (1) DK199588D0 (da)
IE (1) IE64033B1 (da)
WO (1) WO1989009617A1 (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine
DE69131525T2 (de) * 1990-06-13 1999-11-25 Pfizer Inc., New York Pasteurella multocida toxoid enthaltende impfstoffe
DK120792D0 (da) * 1992-09-30 1992-09-30 Bioteknologisk Inst Protein
WO1994011024A1 (en) * 1992-11-06 1994-05-26 Regents Of The University Of Minnesota Composition protective against p. multocida pasteurellosis infection
GB0204387D0 (en) * 2002-02-26 2002-04-10 Secr Defence Screening process
JP2008502605A (ja) * 2004-06-16 2008-01-31 スマート ドラッグ システムズ インコーポレイティド 徐放性ワクチン組成物
TWI285647B (en) * 2004-08-20 2007-08-21 Univ Nat Chunghsing Prevention, treatment and detection of porcine progressive atrophic rhinitis
CN101496899B (zh) * 2004-08-20 2011-08-24 简茂盛 猪进行性萎缩性鼻炎的预防、治疗与检测
CN1736479A (zh) 2004-08-20 2006-02-22 简茂盛 猪进行性萎缩性鼻炎的预防、治疗与检测
KR101699245B1 (ko) * 2015-12-21 2017-02-13 주식회사 인트론바이오테크놀로지 신규한 파스튜렐라 멀토시다 박테리오파지 Ｐａｓ-ＭＵＰ-1 및 이의 파스튜렐라 멀토시다 균 증식 억제 용도

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293545A (en) * 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
NL8200392A (nl) * 1982-02-03 1983-09-01 Duphar Int Res Werkwijze ter bereiding van een immunogeen van pasteurella multocida.
SE8205892D0 (sv) * 1982-10-18 1982-10-18 Bror Morein Immunogent membranproteinkomplex, sett for framstellning och anvendning derav som immunstimulerande medel och sasom vaccin
US4677070A (en) * 1985-04-26 1987-06-30 Cetus Corporation Pseudomonas aeruginosa exotoxin A antibodies, their preparation and use
DK199588D0 (da) * 1988-04-12 1988-04-12 Nordisk Droge & Kemikalie Vaccine

Also Published As

Publication number Publication date
EP0409895B1 (en) 1994-06-22
US5369019A (en) 1994-11-29
IE64033B1 (en) 1995-06-28
IE891151L (en) 1989-10-12
US6110470A (en) 2000-08-29
EP0409895A1 (en) 1991-01-30
DE68916424T2 (de) 1994-11-10
DE68916424D1 (de) 1994-07-28
ATE107516T1 (de) 1994-07-15
AU3532089A (en) 1989-11-03
WO1989009617A1 (en) 1989-10-19

Similar Documents

Publication Publication Date Title
FI883876A (fi) Menetelmä rokotteen valmistamiseksi streptokokki-infektioita vastaan
HU9203098D0 (en) Living vaccine
EP0793717A4 (en) ORAL IMMUNIZATION BY USING TRANSGENIC PLANTS
ATE359370T1 (de) Heterologe antigene in stämmen zur impfung mit lebendzellen
ATE127345T1 (de) Stressproteine und verwendungen dafür.
FI101632B1 (fi) Menetelmä Bordetella pertussis-toksiinin alayksikön analogien valmistamiseksi ja niitä koodaavia rekombinantti-DNA-molekyylejä
ATE107516T1 (de) Pasteurella-impfstoff.
DK341679A (da) Vaccine mod streptokokker og fremgangsmaade til fremstilling deraf
ATE149569T1 (de) Verfahren zur herstellung von impfstoffen oder toxoiden
GB1492596A (en) Tetanus toxoid and process for its manufacture
IE810618L (en) Pasteurella vaccines
AU601415B2 (en) A process for the purification, solubilization and/or detoxification of protein antigens of bacteria of the bordetella genus using a carbonate buffer and an acellular anti-whooping cough vaccine
Moskophidis et al. Molecular characterization of glycoprotein antigens on surface of Treponema pallidum: comparison with nonpathogenic Treponema phagedenis biotype Reiter
SE8205247D0 (sv) Fiskvacciner
IE921832A1 (en) Fish vaccine
DK230890A (da) Dna-fragment, der koder for et pasteurella multocida-toxin eller for en subsekvens eller analog deraf, ekspressionsvektor, der omfatter dna-fragmentet, mikroorganisme, der udtrykker dette, fremgangsmaade til fremstilling af et pasteurella-multocida-toxin, diagnostisk middel samt anvendelse heraf, vaccine indeholdende et pasteurella-multocida-toxinderivat, anvendelse af pasteurella multocida-t m.m.
KR890000106A (ko) 원생성 기생충 예방용 백신
GB9027901D0 (en) Acellular vaccine

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment